Thiolactomycin is a promising lead in the search for antitrypanosomal agents

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1236, 2000-01, pp. : 19-19

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel antitrypanosomal agents

By Steverding Dietmar Tyler Kevin M

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 8, 2005-08 ,pp. : 939-955

Informa Healthcare

Access to resources Recommend Favorite

Trypanothione as a Target in the Design of Antitrypanosomal and Antileishmanial Agents

Current Pharmaceutical Design, Vol. 7, Iss. 12, 2001-08 ,pp. : 1117-1141

Bentham Science Publishers

Access to resources Recommend Favorite

Bimane cyclic esters, possible stereologues of trypanothione as antitrypanosomal agents. Bimanes 29

By Kosower E. Radkowsky A. Fairlamb A. Croft S. Neal R.

European Journal of Medicinal Chemistry, Vol. 30, Iss. 9, 1995-01 ,pp. : 659-671

Elsevier

Access to resources Recommend Favorite

Biological agents promising in plaque psoriasis

Inpharma, Vol. 1, Iss. 1625, 2008-01 ,pp. : 15-16

Adis International

Access to resources Recommend Favorite

On the Horizon: Promising Investigational Antiretroviral Agents

Current Pharmaceutical Design, Vol. 12, Iss. 9, 2006-03 ,pp. : 1091-1103

Bentham Science Publishers

Access to resources Recommend Favorite